Detalhe da pesquisa
1.
Induction of strong HIV-1-specific CD4+ T-cell responses using an HIV-1 gp120/NefTat vaccine adjuvanted with AS02A in antiretroviral-treated HIV-1-infected individuals.
J Acquir Immune Defic Syndr
; 59(1): 1-9, 2012 Jan 01.
Artigo
Inglês
| MEDLINE | ID: mdl-21963936